Renaissance Technologies's BHC Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 1.18 M shares of Bausch Health Companies Inc. (BHC) worth $7.64 M, representing 0.01% of the portfolio. First purchased in 2018-Q3, this long-term strategic position has been held for 29 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in BHC, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2019, adding 7.43 M shares. Largest reduction occurred in Q2 2020, reducing 5.12 M shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Bausch Health Companies (BHC) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bausch Health Companies (BHC) Trades by Renaissance Technologies
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2018 | +1.9 M | New Buy | 1.9 M | $25.67 |
| Q4 2018 | +230,918 | Add 12.14% | 2.13 M | $18.47 |
| Q1 2019 | +631,500 | Add 29.60% | 2.77 M | $24.70 |
| Q2 2019 | +272,000 | Add 9.84% | 3.04 M | $25.22 |
| Q3 2019 | +2.03 M | Add 66.68% | 5.06 M | $21.85 |
| Q4 2019 | +7.43 M | Add 146.76% | 12.49 M | $29.92 |
| Q1 2020 | +910,550 | Add 7.29% | 13.4 M | $15.50 |
| Q2 2020 | -5.12 M | Reduce 38.21% | 8.28 M | $18.29 |
| Q3 2020 | -4.63 M | Reduce 55.96% | 3.65 M | $15.54 |
| Q4 2020 | -1.66 M | Reduce 45.43% | 1.99 M | $20.78 |
| Q1 2021 | -1.26 M | Reduce 63.35% | 729,360 | $31.74 |
| Q2 2021 | -7,971 | Reduce 1.09% | 721,389 | $29.32 |
| Q3 2021 | -698,089 | Reduce 96.77% | 23,300 | $27.90 |
| Q4 2021 | +91,700 | Add 393.56% | 115,000 | $27.61 |
| Q1 2022 | +1.04 M | Add 903.29% | 1.15 M | $22.86 |
| Q2 2022 | -609,746 | Reduce 52.85% | 544,043 | $8.36 |
| Q3 2022 | -544,043 | Sold Out | 544,043 | $0.00 |
| Q1 2023 | +1.14 M | New Buy | 1.14 M | $0.01 |
| Q2 2023 | -1.14 M | Sold Out | 1.14 M | $0.00 |
| Q4 2023 | +265,289 | New Buy | 265,289 | $8.02 |
| Q1 2024 | -249,689 | Reduce 94.12% | 15,600 | $10.58 |
| Q2 2024 | -15,600 | Sold Out | 15,600 | $0.00 |
| Q3 2024 | +26,600 | New Buy | 26,600 | $8.16 |
| Q4 2024 | +468,572 | Add 1761.55% | 495,172 | $8.06 |
| Q1 2025 | +414,400 | Add 83.69% | 909,572 | $6.47 |
| Q2 2025 | -148,589 | Reduce 16.34% | 760,983 | $6.66 |
| Q3 2025 | +423,689 | Add 55.68% | 1.18 M | $6.45 |
Renaissance Technologies's Bausch Health Companies Investment FAQs
Renaissance Technologies first purchased Bausch Health Companies Inc. (BHC) in Q3 2018, acquiring 1,902,782 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Bausch Health Companies Inc. (BHC) for 29 quarters since Q3 2018. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's largest addition to Bausch Health Companies Inc. (BHC) was in Q4 2019, adding 12,491,799 shares worth $373.77 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 1,184,672 shares of Bausch Health Companies Inc. (BHC), valued at approximately $7.64 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Bausch Health Companies Inc. (BHC) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies's peak holding in Bausch Health Companies Inc. (BHC) was 13,402,349 shares, as reported at the end of Q1 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.